Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:6-Methyltetrahydropterin)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST001680 AN002739 Metabolome of NAFLD in high fat diet mouse model Liver Mouse Fatty liver disease Weill Cornell Medicine Abundance
ST002759 AN004481 Metabolic responses of normal rat kidneys to a high salt intake (Kidney cortex) Kidney cortex Rat Medical College of Wisconsin Area
ST003087 AN005048 Metabolome changes in embryonic CSF (Part 9) CSF Mouse Autism Boston Children's Hospital, Harvard Medical School a.u.
ST003089 AN005052 Metabolome changes in embryonic CSF (Part 11) CSF Mouse Autism Boston Children's Hospital, Harvard Medical School a.u.
ST002775 AN004517 Zebrafish Retina Regeneration Metabolomics - 3 Days Post Crush Eye tissue Zebrafish Eye disease University of Miami Normalized Concentrations
ST003278 AN005369 Metabolomic analysis of Axon Regeneration in Xenopus laevis Retina Eye tissue Frog Eye disease University of Miami Peak area
ST003279 AN005371 Metabolomic analysis of Axon Regeneration in Xenopus laevis Tectum Eye tissue Frog Eye disease University of Miami Peak area
ST003280 AN005373 Metabolomic analysis of Axon Regeneration in Xenopus laevis Optic Nerve Eye tissue Frog Eye disease University of Miami Peak area
ST002776 AN004519 Zebrafish Optic Nerve Regeneration, Tectum Metabolomics - 3 Days Post Crush Eye tissue Zebrafish Eye disease University of Miami Peak Area
ST002066 AN003365 Glutaminase inhibition impairs CD8 T cell activation in STK11/Lkb1 deficient lung cancer Lung Mouse Cancer The Walter and Eliza Hall Institute of Medical Research peak height
ST003036 AN004977 Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 Bacterial cells Pseudomonas aeruginosa Bacterial infection Monash Institute of Pharmaceutical Sciences peak height
ST003179 AN005221 Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 Plasmodium cells Plasmodium falciparum Malaria Monash University Peak height
ST000421 AN000663 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000549 AN000837 Investigating large scale metabolomics in mice serum lacking insulin receptors and IGF-1 receptors Blood Mouse Diabetes Mayo Clinic Peak intensity
ST000566 AN000870 Large Scale C18 Profiling of the Effects of Curcumin Supplementation of Older Adults: Relation to Vascular Function Blood Human Heart disease Mayo Clinic Peak intensity
ST000567 AN000872 Large Scale HILIC Profiling of the Effects of Curcumin Supplementation of Older Adults: Relation to Vascular Function Blood Human Heart disease Mayo Clinic Peak intensity
ST001202 AN002000 Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites Cultured cells Human Malaria Monash University Peak intensity
ST001202 AN002000 Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University Peak intensity
ST001204 AN002004 Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Human Malaria Monash University Peak intensity
ST001204 AN002004 Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University Peak intensity
ST001205 AN002006 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Human Malaria Monash University Peak intensity
ST001205 AN002006 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University Peak intensity
ST002094 AN003421 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic raw intensity
ST000046 AN000076 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000046 AN000077 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000047 AN000080 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST002108 AN003448 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) Blood Plasmodium falciparum Malaria Monash University relative intensity
ST002551 AN004200 Metabolomics dataset of CNTF induced axon regeneration in mice post optic nerve crush Eye tissue Mouse Eye disease University of Miami µg/ml
ST002111 AN003454 Metabolomics dataset of optogenetic axon regenerative mouse model post optic nerve crush Eye tissue Mouse Eye disease University of Miami µg/mL
  logo